Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection

BACKGROUND: Aberrant expression of interleukin-35 (IL-35) has been implicated in dampening antitumour immunity. The aim of this study was to explore the prognostic significance of IL-35 expression in patients with hepatocellular carcinoma (HCC) following curative resection. Furthermore, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yi-Peng, Yi, Yong, Cai, Xiao-Yan, Sun, Jian, Ni, Xiao-Chun, He, Hong-Wei, Wang, Jia-Xing, Lu, Zhu-Feng, Huang, Jin-Long, Cao, Ya, Zhou, Jian, Fan, Jia, Qiu, Shuang-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984866/
https://www.ncbi.nlm.nih.gov/pubmed/27002937
http://dx.doi.org/10.1038/bjc.2016.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984866/
https://www.ncbi.nlm.nih.gov/pubmed/27002937
http://dx.doi.org/10.1038/bjc.2016.47

Ejemplares similares